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Trefoil peptides: Tff1, Tff2 and Tff3, assigned to the so-called trefoil factor family (TFF), are
secretory proteins predominantly expressed by the gastrointestinal (GI) epithelial cells. Their
multiple protective functions include an important role in immune response and apoptosis.
Here, a novel localization of Tff2 and Tff3 in the cochlea of mouse inner ear is presented. Tffs
expression and localization in mouse cochlea was analyzed by using the quantitative real time
PCR (qPCR) and immunohistochemistry. Tff2 and Tff3 mRNA quantification by qPCR showed
their presence in the cochlea. Immunohistochemistry demonstrated the presence of Tff2 in the
spiral ligament and limbus and for Tff3 in the spiral ligament and the organ of Corti. These
new and surprising findings of Tff’s presence in the cochlea indicate a new role of TFFs













To hear, our ears must capture mechanical energy that is
carried by sound, transmit it to the ear’s receptive organ,
and transduce it into electrical signals suitable for analysis
by the nervous system. These three tasks are the func-
tions of the external ear, the middle ear, and the inner ear
(cochlea). Cochlea (Figure 1) is the snail-shaped recep-
tor organ of the inner ear which transduces sound energy
into electrical signals and forwards them to the brain.1
Three types of epithelia are present in the cochlea: sen-
sory epithelia (organ of Corti), ion transporting epithelia
(stria vascularis and dark cell regions of the vestibular
system) and relatively unspecialized epithelia (Reissner’s
membrane and epithelia forming permeability barriers).2
Defense of the inner ear against infection occurs through
immune response where inner cells begin to secrete che-
mical attractants and recruit inflammatory cells.3,4 Low
molecular weight proteins, secreted by mucin-producing
epithelia cells, known as trefoil peptides (TFFs)5 are in-
volved in immune response in different ways. They par-
ticipate in the mucosal immune response by stimulating
immunocyte migration6 and are considered as a novel class
of cytokines that modulate immune system.7,8 TFFs are
predominantly expressed in GI tract but also in other tis-
sues as the respiratory tract, salivary glands, uterus, con-
junctiva and even brain.9 The physiological functions of
trefoils are multiple. They enhance mucosal healing by
promoting migration of epithelial cells whereas their ex-
pression in the brain suggests their possible function as
neuropeptides.10 Their presence and possible role in the
organ of hearing have not been analyzed so far due to
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complicated procedure of cochlea preparation. Consider-
ing the role of trefoils in immune response regulation and
the existence of highly specialized epithelium in the in-
ner ear we wanted to analyse the presence of trefoils in
the inner ear.
We have detected expression of Tff2 and Tff3 pro-
teins in the mouse inner ear by demonstrating the pre-
sence of Tff2 mainly in the spiral ligament and Tff3 in
the organ of Corti of the cochlea. The role of trefoils in
the inner ear still needs to be evaluated. Growing eviden-
ce supports the concept that immune reactions occur in
the cochlea, where they can function either in protection
or as a source of inflammation.11 Recently published
data about the role of trefoils (mostly TFF2 and TFF3)
in immune defense7,8 may indicate their possible role for
the inner ear immunity.
EXPERIMENTAL
RNA Isolation and Quantitative Real Time PCR
(qPCR)
After micro-homogenisation (B. Braun Biotech Internatio-
nal) of various mouse tissues from 5 animals, total RNA was
isolated from colon and cochlea of Tff3 wild-type/knock-out
mice, from stomach and cochlea of Tff2 wild-type/knock-
out mice with the RNeasy Mini Kit (Qiagen), and transcrib-
ed into cDNA (iScript cDNA Synthesis Kit; Bio-Rad).
Quantitative Real Time PCR (qPCR) was performed using
iQ SYBR Green Supermix (Bio-Rad) on an iCycler (Bio-
Rad). Specificity and efficiency of PCR reactions were ve-
rified by using the melting curve method and gel electro-
phoresis respectively. Comparison of melting curve profiles
confirmed that a weak signal in knock-out animals (cycle
threshold, Ct, was about 32) is an artefact. PCR was per-
formed using the specific primer pair for Tff3 (mTff3_3F:
5'-AACCGTGGCTGCTGCTTT-3' and mTff3_3R: 5'-
CCTGGAGCCTGGACAGCTT-3') and Tff2 (mTff2_3F:
5'-CTTGGTGTTTCCACCCACTT-3' and mTff2_3R: 5'-
CACCAGGGCACTTCAAAGAT-3'). Since the expression
of GAPDH was stable in stomach, colon and cochlea we
used it as an internal control detected by following primer
pair: mGAPDH_4F: 5'-AACGACCCCTTCATTGAC-3' and
mGAPDH_4R: 5'- TCCACGACATACTCAGCAC-3'. The
PCR conditions were: denaturation at 95 °C for 3 min, fol-
lowed by 35 cycles at 95 °C for 25 s, 58 °C for 20 s and
72 °C for 10 s, ended with 95 °C for 1 min. Data were cal-
culated by using the REST-mcs-beta program.12
Tissue Preparation
The cochleae were rapidly removed, fixed by immersion
for 2 hours in 2 % paraformaldehyde and cryosectioned as
described by Knipper et al.13 Care and use of the animals
and the experimental protocol were reviewed and approved
by the animal welfare commissioner and the regional board
for scientific animal experiments in Tübingen.
Immunostaining Procedure
Immunohistological analyses were performed from cochlea
samples taken from three to five wild-type mice at day
(P22). Formalin-fixed paraffin-embedded specimens of mouse
cochleae were used. Five-micron sections were cut from
the paraffin blocks, routinely processed through xylene and
alcohol gradient, treated with methanolic hydrogen peroxide
to eliminate the endogenous peroxidase activity, and then
immunostained. We used polyclonal antibodies that were
immunopurified to eliminate the unspecific staining. To re-
duce background staining sections were treated with normal
goat serum 1:20 (Vector Laboratories). After being rinsed
in PBS + 0.05 % Tween, sections were incubated overnight
at +4 °C with primary antibody rabbit anti-mouse Tff2 (dil.
1:400) or rabbit anti-human Tff3 (dil. 1:10000). Sections
were washed with PBS + 0.05 % Tween before biotinylated
secondary goat anti-rabbit antibody was applied for 35 min
at room temperature, followed by extensive PBS + 0.05 %
Tween rinses and incubation with streptavidine and horse
radish peroxidase (dil. 1:400) for 35 min at room tempera-
ture. Specificity of staining was confirmed by including
controls were we preincubated antibodies with their speci-
fic peptides. Immunohistochemical signals were visualized
with 0.5 mg ml–1 3',3-diaminobenzidine (DAB, Sigma-Al-
drich) in 0.1 mol dm–3 PBS and 0.01 % H2O2. Sections were
imaged using an Olympus AX-70 microscope. Representa-
tive images were chosen for presentation.
RESULTS
TFF2 and TFF3 Expression in the Cochlea
Quantitative real time PCR (qPCR) revealed that Tff2 and
Tff3 are expressed in the cochlea (Ct value was 27 and
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Figure 1. A paraffin section of the mouse cochlea. The three fluid-
filled spaces of scala vestibuli, scala media and scala tympani are
separated from each other by Reissner’s membrane and basilar
membrane. The stria vascularis (SV) and spiral ligament (SL) lie
close to the lateral wall of the cochlea. The organ of Corti (in a
frame) contains one inner hair cell (IHC), three outer hair cells
(OHC) and supporting cells. Spiral ganglion (SG) is in the modio-
lus. Bar: 200 µm.
28 respectively) of adult mouse beside their presence in
control tissues: stomach and colon (Ct value was 13 and
15 respectively). No expression was found in tissues of
corresponding knock-out animals (Ct value  32). The
expression of GAPDH was stable in the stomach, colon
and cochlea (Ct values were 15–16) (Table I).
Localization of Tff2 and Tff3 Proteins in the
Cochlea
Our immunohistochemical data demonstrated for the first
time an expression pattern for Tff2 and Tff3 proteins in
the cochlear tissues of adult mice. Immunochemistry re-
vealed Tff2 (Figure 2) and Tff3 staining in various areas
of the cochlea (Figure 3). The highest expression for Tff2
was detected in the spiral ligament and limbus and for
Tff3 in the spiral ligament and in the organ of Corti. The
protein-antibody interaction was completely abolished
upon pre-incubation with synthetic Tff2 and Tff3 pepti-
de (Figure 2 and Figure 3).
DISCUSSION
TFFs are multifunctional peptides and since 1989 it has
been well documented that TFFs are expressed along the
length of the normal GI tract where they maintain epi-
thelial surface integrity5 and in various other tissues.9 Here
for the first time we have identified the Tffs’ presence in
the specific sections of the mouse inner ear. Tff2 is
present in the spiral ligament and limbus while Tff3 is
located in the spiral ligament and the organ of Corti of
the mouse inner ear. Similar situation was noted for the
rat inner ear (data not shown). Tffs have multiple roles
in the organism. They can serve as motogens, are linked
to anti-apoptosis, can trigger chemotaxis and could be in-
volved in neoplastic development.5 Their presence in the
inner ear could have an immune response related role.
It is known that expression of TFFs is modulated
(mainly up-regulated) in response to inflammation, inju-
ry and repair.5 TFF2 is expressed in immune response
relevant tissues like spleen, lymph nodes, bone marrow,6
peritoneal exudate cells (PECs), and primarily macropha-
ges.7 Recent data showing that Tff2 deficiency affects ex-
pression of the immune response relevant genes indica-
tes that Tff2 is involved in some aspects of immune res-
ponse.8 TFF2 functions also as an anti-inflammatory
peptide with specificity for IL-1β signaling and immune
cell cytokine secretion. These data raised the possibility
that Tff2 could regulate inflammation by directly affect-
ing mononuclear cells (lymphocytes and macrophages)
in inflammatory infiltrates.7
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Figure 2. Immunohistochemical localization of Tff2. A positive stain-
ing for Tff2 protein was noticed in fibrocytes of spiral ligament and
limbus (left). Immunostaining was blocked with the specific pep-
tide (right). Bar: 50 µm.
Figure 3. Immunohistochemical localization of Tff3. Tff3 was ex-
pressed in the organ of Corti and spiral ligament (left). Immuno-
staining was blocked with the specific peptide (right). Bar: 50 µm.





Stomach wildtype 1 Colon wildtype 1
Stomach knockout −322737 Colon knockout −24833
Cochlea wildtype −9674 Cochlea wildtype −3717
Cochlea knockout −1123835 Cochlea knockout −114104
(a) Expression is given with respect to the expression level in stomach or colon of normal mice (set to 1).
Uncontrolled prolonged inflammatory reactions cause
tissue damages as a consequence of biologically active
molecules released by activated inflammatory cells. In-
flammation occurs also in the inner ear where may have
been responsible for the hearing loss caused by degene-
ration of the organ of Corti, stria vascularis, spiral gang-
lion cells, spiral ligament and limbus.14 Fibrocytes of the
spiral ligament play an important role in the inner ear
homeostasis.15 They are also involved in the innate im-
mune response of the inner ear by producing chemoat-
tractants for recruiting inflammatory cells such as neu-
trophils and monocytes.16 In vitro, fibrocytes secrete che-
mokines after stimulation by the pro-inflammatory cyto-
kines TNF-á and IL-1â demonstrating their ability to
respond to signals used by leukocytes for cell-cell sig-
naling.17 The same cytokines that are produced during
wound healing (TNF-á, IL-1â and IL-6)18 are also pro-
duced by cochlear cells in the early response to acoustic
trauma (noise-induced hearing loss).19 Macrophages
contribute to wound healing through the secretion of cy-
tokines and growth factors such as TNF-á, IL-1â, IL-6,
TGF-á and TGF-â, and insulin like growth factor-1.18 It
seems that fibrocytes and macrophages function together
to mediate cochlear repair following trauma. Immune
response crucial modulating transcription factor NF-êB
is commonly found in the inner ear, demonstrating the
capability of the cochlea to respond to immunostimula-
tion.20 TFFs expression is strongly controlled by NF-êB21
and downregulated in case of prolonged inflammation. The
presence of Tff2 protein in the fibrocytes together with
the knowledge about possible role of fibrocytes and Tff2
in immune regulation may indicate that TFFs may play
an important role in the inner ear immune response.
A number of studies suggest that nitric oxide (NO)
plays an essential role in the pathophysiology of the in-
ner ear including inflammation and immune response.22
TFFs are able to modulate production of NO.23,24 In acu-
te injury NO is produced by constitutively active nitric
oxide synthase (cNOS) and it has beneficial effect by in-
creasing blood flow and releasing various local repair
mediators.25 In chronic inflammatory states, NO is ge-
nerated by inducible nitric oxide synthase (iNOS) within
infiltrating macrophages and neutrophils26 leading to
production of highly damaging reactive nitrogen species
that induce further inflammation, leading to ongoing tis-
sues injury.27 It is shown that TFF3 stimulates NO pro-
duction23 while TFF2 is able to inhibit LPS-induced NO
production in a monocyte cell line.24 In addition to its
role in immune response28 NO can also regulate intra-
cellular Ca2+-concentrations in the inner and outer hair
cells, thus influencing their mechanical properties as well
as neurotransmission at synapses of the auditory nerve.
It may also interfere with the metabolism of secretory
cells in the stria vascularis by influencing ionic pumps.
The findings that NO can induce apoptosis in the outer
hair cells of the organ of Corti suggests the possibility
that the cochlea is affected when extra NO release oc-
curs there, leading to cochlear dysfunction.29 Apoptosis
appears to play a critical role in the pathogenesis of
hearing loss. It is known that caspases 8, 9, and 3 are in-
volved in the apoptosis of physically damaged hair cells30
and caspases 5 and 6 are suggested to participate31 while
caspases 7 and 10 are thought to be involved in the
process of apoptosis of physical trauma-damaged hair
cells.32 It is known that trefoil peptides play an anti-
apoptotic role15,33,34 what may suggest their role in pre-
venting apoptosis in the organ of hearing.
It is interesting to note that our knowledge about the-
se primarily gastrointestinal factors is growing and bring-
ing new, important facts about their function. We present
new data about the surprising presence of trefoil pepti-
des in the inner ear. The role of TFFs is evolving from
that simple secretory proteins interacting with mucins
towards more complex proteins involved in various as-
pects of inflammatory reactions, anti-apoptotic mecha-
nism, and possibly in physiology of cells in specialized
organs like cochlea. The exact role of Tffs in the cochlea
still has to be elucidated and the present data about their
antiapoptotic and immunomodulating7,13 role in the gas-
trointestinal tract as a predominant site of expression could
be a good guide.
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Novootkrivena lokalizacija TFF proteina s domenom trostruke om~e:
prisutnost Tff2 i Tff3 u pu`nici glodavaca
Maria Lubka, Carsten M. Pusch, Nikolaus Blin i Mirela Baus-Lon~ar
TFF proteini: Tff1, Tff2 i Tff3 pripadaju takozvanoj TFF obitelji proteina (engl. Trefoil Factor Family) sa
strukturnom domenom sli~nom listu djeteline (engl. trefoil). Tff proteini su predominantno prisutni u probav-
nom traktu kao sekretorni produkt epitelnih stanica probavnoga trakta. Za{titna je uloga Tff proteina vi{estruka
i uklju~uje sudjelovanje u imunosnom odgovoru i apoptozi. U ovom je radu prikazana novodokazana prisutnost
Tff proteina u senzornom dijelu unutra{njeg uha mi{a, tj. u pu`nici. Prisutnost i raspodjela Tff proteina u pu`ni-
ci pra}ena je pomo}u kvantitative reakcije lan~ane polimeraze (qPCR) i imunohiostokemijski. qPCR metoda
pokazala je prisutnost Tff2 i Tff3 glasni~ke RNA u pu`nici, a imunohistokemijskom metodom je pokazana pri-
sutnost Tff2 u spiralnom ligamentu i limbusu, tj. za Tff3 u spiralnom ligamentu i Kortijevu organu. Ova izne-
na|uju}a prisutnost Tff proteina u pu`nici upu}uje na novu ulogu Tff proteina povezanu s organom sluha koja
zahtijeva daljnje fiziolo{ko poja{njenje.
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